Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985;61(1-2):43-53.
doi: 10.1007/BF01253050.

Effect of beta-adrenoceptor agonists on apomorphine-induced turning in rats

Effect of beta-adrenoceptor agonists on apomorphine-induced turning in rats

R Ortmann et al. J Neural Transm. 1985.

Abstract

The beta-adrenoceptor agonists clenbuterol, salbutamol and formoterol were found to inhibit apomorphine-induced turning behavior in rats with unilateral nigrostriatal lesions. The inhibitory effect of clenbuterol was antagonized by (-)-propranolol, but unaffected by practolol (which does not cross the blood-brain barrier), indicating a central localization of the beta-adrenoceptors mediating the inhibitory effect. A dopamine-releasing activity of clenbuterol did not seem to be responsible for the effect, because known dopamine-releasing agents (amphetamine, methylphenidate) did not antagonize apomorphine-induced turning behavior. Furthermore alpha-methyl-p-tyrosine pretreatment did not prevent the inhibitory effect of clenbuterol. Since L-5-hydroxytryptophan did not mimic the inhibitory effect of clenbuterol, it was concluded that the inhibition of turning behavior is not mediated by the interaction of clenbuterol with the serotonin system. The finding that clenbuterol depressed locomotor activity in the same dose range as it inhibited apomorphine-induced turning tentatively suggests that clenbuterol inhibits apomorphine-induced turning behavior by its central beta-adrenoceptor mediated sedative action.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Naunyn Schmiedebergs Arch Pharmacol. 1981 Jun;316(3):225-30 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1979 Jun;307(2):115-22 - PubMed
    1. Eur J Pharmacol. 1976 Oct;39(2):179-91 - PubMed
    1. Mol Pharmacol. 1976 Jul;12(4):568-80 - PubMed
    1. Psychopharmacology (Berl). 1983;81(1):1-5 - PubMed

LinkOut - more resources